Torrent Pharmaceuticals Ltd.

Financial

	Torrent Pharma	Mankind Pharma	Dr. Reddy's Lab
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	168.0 .	60.0 .	354.0 .
Number of ANDA's Approved By USFDA	132.0 .	44.0 .	275.0 .
Domestic Sales Growth - YoY	12.8 %	n/a	9.3 %
R&D as a % of Total Sales	5.4 %	2.15 %	8.0 %
Financials
5 yr Average ROE	20.0 %	23.46 %	14.9 %
5yr average Equity Multiplier	2.34	1.37	1.41
5yr Average Asset Turnover Ratio	0.65	0.95	0.77
5yr Avg Net Profit Margin	13.21 %	17.9 %	14.03 %
Price to Book	15.04	9.99	3.26
P/E	60.63	51.72	18.64
5yr Avg Cash Conversion Cycle	-189.03 Days	-44.05 Days	64.1 Days
Inventory Days	54.5 Days	58.78 Days	75.39 Days
Days Receivable	41.38 Days	24.18 Days	99.54 Days
Days Payable	318.84 Days	130.75 Days	102.35 Days
5yr Average Interest Coverage Ratio	5.79	56.97	34.06
5yr Avg ROCE	23.72 %	30.07 %	19.83 %
5yr Avg Operating Profit Margin	29.52 %	24.6 %	21.19 %
5 yr average Debt to Equity	0.83	0.05	0.12
5yr CAGR Net Profit	10.08 %	13.17 %	22.45 %
5yr Average Return on Assets	8.58 %	17.12 %	10.71 %
Shareholdings
Promoter Holding	68.31 %	72.7 %	26.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.94 %	-3.8 %	-0.08 %
Change in Mutual Fund Holding (3 Yrs)	-2.45 %	5.84 %	-1.23 %

Business

	Torrent Pharma	Mankind Pharma	Dr. Reddy's Lab
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 42.15 US Formulations 20.71 Germany 13.15 Brazil 8.98 Contract Manufacturing 6.15 Urology 0 Neuro/CNS 0 Pain/Analgesics 0 Gynaecology 0 Dermatology 0 Anti-Diabetic 0 Respiratory 0 VMN 0 Gastro - Intestinal 0 Cardiovascular 0 Anti-infectives 0 Proprietary Products 0 Global Generics 0 0 Others 8.86	Product Wise Break-Up Anti-Diabetic 9.0 Urology 2.0 Contract Manufacturing 0 Gastrointestinal 9.0 Dermatology 5.0 VMN 8.0 US Formulations 0 Domestic Formulations 0 Germany 0 Neuro/CNS 5.0 Brazil 0 Gynaecology 10.0 Global Generics 0 Anti-infectives 14.0 Respiratory 8.0 Cardiovascular 15.0 Pain/Analgesics 4.0 Proprietary Products 0 0 Others 11.0	Product Wise Break-Up Anti-Diabetic 0 Urology 0 Contract Manufacturing 0 Gastro - Intestinal 0 Dermatology 0 VMN 0 US Formulations 0 Domestic Formulations 0 Germany 0 Neuro/CNS 0 Brazil 0 Gynaecology 0 Formulations 88.24 Anti-infectives 0 Respiratory 0 Cardiovascular 0 Pain/Analgesics 0 Proprietary 1.93 Pharmaceutical 9.83
Location Wise Break-Up	Location Wise Break-Up India 56.28 Brazil 10.36 Germany 10.04 USA 9.65 Nepal 0 Sri Lanka 0 Bangladesh 0 Russia 0 Others 13.67	Location Wise Break-Up USA 0 India 86.0 Bangladesh 0 Sri Lanka 0 Russia 0 Brazil 0 Nepal 0 Germany 0 Others 14.0	Location Wise Break-Up USA 48.56 India 17.36 Bangladesh 0 Sri Lanka 0 Russia 7.99 Brazil 0 Nepal 0 Germany 0 Others 26.09
Acute vs Chronic	Acute vs Chronic Chronic 75.0 Acute 25.0 Sub - chronic 0	Acute vs Chronic Chronic 37.6 Acute 62.4 Sub - chronic 0	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiac Science 26.0 Gastro Intestinal 17.0 CNS 15.0 VMN 12.0 Anti - Diabetes 9.0 Pain Management 7.0 Anti-Infective 3.0 Gynecology 2.0 Rest 2.0 Respiratory 0 Anti-Infective 0 Central Nervous System 0 Pain Management 0 Cardiovascular 0 Oncology 0 Gastrointestinal 0 Others 7.0	-	Therapeutic Area Break-Up Pain Management 9.77 VMN 0 Respiratory 7.04 Cardiac Science 6.65 Rest 0 Gynecology 0 Oncology 27.53 CNS 0 Anti-Infective 6.48 Central Nervous System (CNS) 12.12 Cardiac Science 0 Anti - Diabetes 0 Gastro Intestinal 9.52 Gastro Intestinal 0 Others 20.89
Asset Break-Up	Asset Break-Up India 96.58 United States 0 Switzerland 0 Others 3.42	-	Asset Break-Up USA 2.37 Switzerland 8.45 India 80.24 Others 8.94

Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

SIGN UP FOR FREE